Literature DB >> 7659440

Influence of timing on the analgesic effect of intravenous ketorolac after orthopedic surgery.

D Fletcher1, P Zetlaoui, S Monin, M Bombart, K Samii.   

Abstract

This study evaluated the pre-emptive analgesic effect of intravenous (i.v.) ketorolac (KET) for total hip replacement (THR). Sixty patients who underwent surgery for THR under general anesthesia were randomly allocated to 3 groups. Two i.v. injections were administered: one before induction and one after surgery. The patients were studied prospectively in a double-blind manner. The control group (CONT; n = 20) received 2 ml of normal saline (NS) for both injections. The pre-operative KET group (PRE; n = 20) received 60 mg of KET and then 2 ml of NS. The postoperative KET group (POST; n = 20) received 2 ml of NS and then 60 mg of KET. General anesthesia was standardized with a intra-operative cumulated dose of fentanyl limited to 4 micrograms/kg. In the recovery room (RR), pain was controlled with an i.v. tritration of morphine; thereafter, on the surgical ward, patients used a patient-controlled analgesia (PCA) pump (Abbott). Pain was evaluated with a visual analogue scale (VAS) at rest and movement in the RR, then every hour for 6 h and every 6 h for 5 days. The side effects monitored were: sedation, respiratory depression, nausea, perioperative bleeding. The patients and surgery were similar for the 3 groups. Upon arrival in the RR, VAS scores taken at rest and at movement were lower for the PRE group than for the CONT and POST groups. Otherwise, VAS scores were similar in all 3 groups. The cumulative dose of morphine in the PRE group was lower than that for the CONT and POST groups from 0 to 6 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7659440     DOI: 10.1016/0304-3959(94)00184-G

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  17 in total

1.  Preoperative administration of intravenous flurbiprofen axetil reduces postoperative pain for spinal fusion surgery.

Authors:  Kazunori Yamashita; Makoto Fukusaki; Yuko Ando; Arihiro Fujinaga; Takahiro Tanabe; Yoshiaki Terao; Koji Sumikawa
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 2.  What is the role of NSAIDs in pre-emptive analgesia?

Authors:  E Andrew Ochroch; Issam A Mardini; Allan Gottschalk
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  Maximizing the safety of nonsteroidal anti-inflammatory drug use for postoperative dental pain: an evidence-based approach.

Authors:  K S Ong; R A Seymour
Journal:  Anesth Prog       Date:  2003

Review 4.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

5.  Comparison of preemptive analgesic effects of a single dose of nonopioid analgesics for pain management after ambulatory surgery: A prospective, randomized, single-blind studyin Turkish patients.

Authors:  Mesut Sener; Zafer Ozgur Pektas; Ismail Yilmaz; Ayda Turkoz; Sina Uckan; Asli Donmez; Gulnaz Arslan
Journal:  Curr Ther Res Clin Exp       Date:  2005-11

6.  The influence of timing of administration on the analgesic efficacy of parecoxib in orthopedic surgery.

Authors:  Valéria Martinez; Anissa Belbachir; Aithem Jaber; Kamel Cherif; Adel Jamal; Yves Ozier; Daniel I Sessler; Marcel Chauvin; Dominique Fletcher
Journal:  Anesth Analg       Date:  2007-06       Impact factor: 5.108

Review 7.  [Pain therapy for the lower extremities].

Authors:  C J P Simanski
Journal:  Orthopade       Date:  2008-10       Impact factor: 1.087

Review 8.  Nonsteroidal anti-inflammatory drugs for postoperative pain: a focus on children.

Authors:  Hannu Kokki
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Comparison of Pain Relief from Different Intravenous Doses of Ketorolac after Reduction of Mandibular Fractures.

Authors:  Saeed Nezafati; Reza Khorshidi Khiavi; Seyyed Sina Mirinejhad; Dawood Aghamoh Ammadi; Milad Ghanizadeh
Journal:  J Clin Diagn Res       Date:  2017-09-01

10.  Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief.

Authors:  B Renner; G Walter; J Strauss; M F Fromm; J Zacher; K Brune
Journal:  Eur J Pain       Date:  2011-12-19       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.